TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Investor Securities Class Action Lawsuit 12/20/2021

  • If you purchased a significant amount of shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between November 9, 2020 and December 8, 2021, and / or if you purchased any NASDAQ: RETA shares prior to November 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 18, 2022. NASDAQ: RETA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

December 12/202/201 - An investor in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) filed a lawsuit in the U.S. District Court for the Eastern District of Texas over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between November 9, 2020 and December 8, 2021. Plano, TX based R...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)